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1. Abstract:
The presence of pathogens in the human body influences the expression of proinflammatory cytokines by activated immune cells. These cytokines, and other factors, regulate
osteoclastogenesis and osteoclast activity. Through experimental osteoimmunology, interactions
between the inflammatory response and bone cell physiology may provide insight into how
immune processes can be translated into the lesions or abnormalities observed in the osteological
record. In this research, our objective was to determine if the cytokines produced by activated
immune cells increase osteoclastogenesis and osteoclast activity. To evaluate this hypothesis, we
used two main protocols, one for immune activation and one for osteoclastogenesis, that utilized
peripheral blood mononuclear cells (PBMCs) from healthy donors. The results of these protocols
indicated that cells exposed to Tp47, an antigen of Treponema pallidum, produce relatively more
TNFα and IFNg than cells not exposed to infectious stimuli, yet osteoclastogenesis conditions
exposed to Tp47 supernatants produced only slightly more osteoclasts than conditions exposed to
untreated supernatants. After preliminary data, this outcome indicates that higher concentrations
of TNFα and IFNg may not be connected to increased osteoclastogenesis. Further research is
needed to increase the sample size, allowing for statistical analyses that control for the high intersample variability.
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2. Lay Summary:
The presence of pathogens in the human body influences the production of immune
proteins commonly associated with inflammation. These immune proteins can regulate the
generation of bone cells. Interactions between the immune and skeletal systems may provide
insight into how the processes of the immune system can be translated into the abnormalities
observed in skeletal samples, particularly archaeological or historical samples. In this research,
our goal was to determine if proteins produced by activated immune cells increase bone cell
generation and activity, ultimately affecting bone structure and function. To evaluate this, we
used two main strategies: 1. stimulate immune cells by proteins from pathogen Treponema
pallidum. This pathogen generates a chronic infection in humans, altering inflammation and bone
structure, and 2. from same donor blood cells, generate bone cells. Ultimately, we explored how
T. pallidum immune activated cells can alter the production of bone cells. The results indicated
that cells exposed to T. pallidum proteins, produce relatively more inflammatory proteins than
untreated cells, or cells not exposed to stimuli. Interestingly, the conditions introduced to liquids
containing what was produced by T. pallidum activated immune cells yielded only slightly more
bone cells (osteoclast) when compared with conditions with bone cells that were not introduced
to those liquids. This outcome indicates that these inflammatory proteins do not seem connected
to increased bone cell formation. However, further research is needed to increase the sample
size, allowing for statistical analyses that address the high level of difference between individual
samples.
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3. Introduction
a. Inflammation, systemic inflammation, and immunopathology
Human populations vary in terms of immune response type and strength, which relates to
disparities between the expression of immune proteins. Immune responses to stimuli can cause
inflammation, a complex reaction initiated by cytokines that results in the mobilization of other
immune cells and plasma proteins to the injury or infected area (Abbas and Lichtman 2005).
Immune system regulation works within a deeply rooted and redundant networks where cytokines
interact in both supporting and opposing manners (Ollier 2004). Cytokine network development is
impacted by the combination of host and pathogen biology (Wilson et al. 1998). A state of hyperinflammation can occur when cytokines that promote inflammation escape their localized area and
start circulating on a systemic level. One such cytokine, tumor necrosis factor alpha (TNFα), is an
inflammation mediator that can impact the activation of immune cells when it escapes. This can
also lead to a change in host physiology (Strieter et al. 1993). With these factors in mind, infection
and injury can leave a lasting impact on the body and may contribute to chronic diseases even if
the original cause of infection is no longer a factor (Ewald 2002).
Although the immune system typically serves as protection against harmful pathogens, it
can negatively impact the body when not properly regulated. A malfunction of sorts can lead to
tissue damage and other diseases, such as those conditions classified as autoimmune diseases. At
one extreme, inadequate responses make the host more vulnerable to pathogens. Alternatively,
excessive responses can induce hyper-inflammation and impact host pathology on local and
systemic levels (Graham et al. 2005). Changes in the expression of cytokines caused by one
infection can influence the progression of other infections (Stelekati and Wherry 2012). With this
in mind, dormant infections (such as tuberculosis or syphilis) have the potential to generate a
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cytokine expression that yields long-lasting cross protection in the face of multiple pathogens
(Barton et al. 2017). In humans that produce a greater immune response, chronic infections, could
promote a systemic change in inflammatory proteins, ultimately affecting the host biology.
The dual effect of the immune system, fighting infection while causing immunopathology,
is driven by two broad classes of mechanisms, namely, cytotoxicity and tissue remodeling. The
recruitment of cells and the release of different immune mediators (i.e., cytokines) and toxic
chemicals are part of the normal function of the immune response. However, when uncontrolled or
unbalanced, the same protective response can lead to tissue immunopathology. An abnormal
inflammatory response can be linked to an over-reactive immune response or “hyper-inflammatory
phenotype” (HIP) (Graham et al., 2005; Shaddox et al., 2010). This underscores the important
point that chronic infections or stressors promote a long-term inflammatory response, and
wherever inflammatory conditions or diseases occur, systemic impacts on bone develop on some
level (Klaus, 2014).

b. Osteoimmunology: a window to immunopathology in skeletal samples?
Osteoimmunology, an area of increasing interest, is the study of the interactions between
the immune and skeletal systems (Lorenzo et al. 2011; Nakashima and Takayanagi 2009). The
osteoclast, a cell that breaks down bone tissue, is a fundamental part of the immune and skeletal
system interaction (Faccio et al. 2011). Cytokines are also essential to this interaction.
Furthermore, the majority of immune cells share a developmental microenvironment as they are
produced by cells in the bone marrow (Takayanagi 2007). Therefore, this interaction and the
activity of cells in these systems are critical to the regulation of bone remodeling.
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Osteoclasts serve an important purpose in bone remodeling within the skeletal system.
They have the ability to reduce the bone matrix’s organic and inorganic components (Faccio et al.
2011). Osteoclastogenesis, the differentiation of cells into osteoclasts, is controlled by complicated
process involving the receptor activator of nuclear factor-κB ligand (RANKL) (Nakashima and
Takayanagi 2009; Takayanagi 2007). One study that utilized a mouse model showed that
interrupting RANKL and its receptor, RANK, resulted in significant osteopetrosis and teething
problems because of the absence of osteoclasts (Nakashima and Takayanagi 2009). The fact that
activated T cells exhibit RANKL as well indicates that these immune cells can differentiate into
osteoclasts. Furthermore, increased osteoclast activity caused by T-cell hyper-activation can result
in pathology (Kong et al. 1999).
Cytokines, and other factors, regulate osteoclastogenesis and osteoclast activity. One
method of control is through the expression of RANKL and RANK (Lee et al. 2008; Moon et al.
2013; Souza and Lerner 2013; Zupan et al. 2013). Macrophage colony-stimulating factor (M-CSF)
is a cytokine that is essential to the immune and bone cells interactions that control
osteoclastogenesis. It influences the motility and replication of osteoclast precursors (Takayanagi
2007). TNFα serves a similar function in osteoclastogenesis. Research has shown that dispensing
systemic TNFα increases the formation of osteoclasts in mice (Stashenko et al. 1987).
Alternatively, this cytokine also serves as an osteoblast inhibitor, reducing the function of cells and
the formation of bone (Faccio et al. 2011).
Interestingly, cytokines, including TNFα, can assist in linking hyperinflammation with
bone remodeling/resorption characteristic of different bone lesions like periodontal disease (PD),
periosteal lesions (PL), and osteomyelitis (OM). Pathogens involved in PD, PL, and especially OM
are also important in the cross talk between immune cells and bone cells. For example, oral
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pathogen Porphyromonas gingivalis may influence osteoclast formation either by interacting
directly on osteoclast or by activating gingival fibroblasts (Scheres et al. 2011). This chronic
inflammatory status leads to bone loss and ultimately possible tooth loss (Irfan et al. 2001). The
alveolar bone loss and exposure of underlying trabecular bone associated with PD are frequently
identified in skeletal remains (Larsen 2015; Ogden 2008), generating an unique opportunity to
study complex and chronic immune-osteological interaction in archaeological samples.

c. Multidisciplinary approach to reconstruct skeletal inflammatory phenotypes: SINDEX
The emerging question and challenge here are: is it possible to reconstruct an individual’s
inflammatory phenotype based on osteological evidence? To start to reconstruct something as
complex and varied as immune competence and an individual’s inflammatory phenotype (IP)
using skeletal samples, multiple perspectives must be engaged to help fill in the puzzle. Here, the
ability of the field of bioarchaeology as a whole to embrace other disciplines, to integrate,
contextualize, and synthesize data from outside the discipline is crucial for a more holistic end
assessment (Klaus 2014; Reitsema and McIlvaine 2014; Temple and Goodman 2014). To
reconstruct an IP using skeletal samples, it was proposed a framework utilizing four prominent
fields of study (Figure 1) (Crespo 2018; Crespo 2020 in press):
1. Experimental immunology: Experiments performed in vitro consider the
mechanisms of inflammation itself, the cellular and chemical mediators of the inflammatory
response. Teasing apart how specific inflammatory factors respond to insults via in vitro models
may provide insights, i.e. how activated immune cells can affect inflammatory responses to variety
of secondary insults, which may then be extrapolated to other levels of analysis.
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2. Osteoimmunology:
Experimental

Osteoinmmunology

Paleopathology

osteoimmunology performed in vitro
provides an opportunity to

SINDEX

investigate the underlying
relationship between the bone at its

Experimental
Immunology

PaleoProteomics

fundamental cellular level and the
immune system, i.e. how activated
immune cells can affect bone cell
differentiation and physiology.
Interactions between the

Figure 1: Diagram representing the multidisciplinary model to reconstruct
skeletal inflammatory index (SINDEX) in skeletal samples.
Osteoimmunology (grey) is the component that is explored in this
Honors Thesis

inflammatory response and bone cell physiology may provide insight into how immune processes
can be translated into the lesions or abnormalities observed in the osteological record.
3. Paleo-Proteomic analysis: This analysis allows for the inquiry of bone at the level of
its proteins. Analyzing proteins from a miniscule sample of powdered bone could potentially
capture the presence of inflammatory (or other stress) markers in the bone postmortem. The
presence of these proteins may be more indicative of the inflammatory processes that occurred in
life, which may or may not have contributed to lesion formation yet were still present. Proteomic
analysis potentially provides a much more powerful understanding of health in life than previously
possible from skeletonized remains alone (Sawafuji et al. 2017; Scott et al. 2016).
4. Paleopathology: This analysis utilizes the basic tools of bioarchaeology to study
disease in the past via analysis of skeletal remains for lesions/alterations commonly associated
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with inflammatory processes. Paleopathology must be consulted as it provides a foundation for
interpreting the diseased skeleton within the context of the other analyses.
This multidisciplinary approach that will integrate paleopathology, osteoimmunology, and
proteomics is emerging to establish a “skeletal inflammatory index” (SINDEX) (Crespo 2018;
Crespo 2020 in press); where, we must recognize that past populations experienced complex
heterogeneous biosocial landscapes consequently allowing us to predict the development of
equally heterogeneous inflammatory landscapes and that is the ultimate challenge for the
theoretical and methodological approach when reconstructing SINDEX.
Clearly, this four-pronged model provides a starting point to frame questions about the
potential of reconstructing past inflammatory processes, with each part contributing a piece to the
puzzle. It is necessary to begin with the experimental immunological component to frame
subsequent analyses by the other fields within this multidisciplinary perspective. An analysis of
bone must be based on the foundation provided by bioarchaeology and paleopathology, but
inflammation cannot be understood in the context of the skeleton without understanding the
mechanisms that occur in life. Osteoimmunology will provide the biological and physiological
foundation necessary when reconstructing the inflammatory phenotype, because it can provide the
basis of understanding of the how and why of the inflammatory process and how it affects bone
structure and physiology. Establishing in vitro models provides the chance to tease out the role, or
at least the responses of specific mediators, not possible elsewhere.
Reducing the inflammatory process to a very simplistic model leaves out the nuances and
confounding factors of real life histories but allows for the study of the basic underlying biological
and molecular mechanisms (osteoimmunology), providing a clearer look at the potential ways that
this process can be initiated, as well as how this information can articulate with the other

12

components of this skeletal inflammatory index. This Senior Honors Thesis is primarily focused on
providing preliminary experimental evidence for the osteoimmunological component of SINDEX,
using a model where testing if immune activation by antigens from Treponema pallidum (pathogen
that produces syphilis) can modify in vitro osteoclast production. The novelty of this project is to
use peripheral blood mononuclear cells (PBMCs) from same donor to induce immune activation
and osteoclastogenesis.

d. Why Treponema pallidum to test SINDEX?
Acquired syphilis is a chronic inflammatory, multi-staged infection produced by the
pathogen Treponema pallidum (Lafond and Lukehart 2006; Salazar et al. 2002). The systemic shift
in the immune system generated by the chronic infection associated with T. pallidum could affect
other chronic infections like those produced by oral pathogens such as periodontal disease (PD).
We believe that localized, chronic inflammation has systemic consequences, influencing the host’s
immunological profile and impacting bone microenvironments through interactions with other
inflammatory processes like the one seen in periodontal disease. Crespo and colleagues (2017)
have proposed that a hyper-inflammatory phenotype generated by chronic, persistent infections,
such as leprosy, may affect other persistent, chronic infections through a systemic exacerbation or
hyperactivation of the cellular immune response. The same process may be at work in host
immune responses to T. pallidum, with the hyper-inflammatory state induced by that pathogen
affecting immune responses to other chronic infection causing pathogens. A hyper-inflammatory
response against T. pallidum may mediate—or, alternatively, be mediated by—hyperinflammatory responses against other pathogens. Recent research suggests that the correlation
between the expression of different pro-inflammatory proteins and the destruction of periodontal
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tissue means that periodontal disease in skeletal samples can be used to indicate the inflammatory
status of the sample (Crespo et al. 2017).
Experts have proposed using periodontal disease to reconstruct the inflammatory condition
of individuals during the stages of acquired syphilis infection (Crespo et al. 2017). However, more
evidence is needed to explore the possible interactions between the systemic inflammation seen in
syphilis and distant changes in bone that involve inflammatory changes seen in periodontal
disease. To further our understanding of this interaction, we investigated whether or not immune
cells activated by T. pallidum and Porphyromonas gingivalis (commonly present in oral infection)
can impact osteoclast differentiation and activity. Consequently, the primary objective of this
research was to determine if exposure to supernatants collected from immune cells stimulated by
T. pallidum antigens or sequentially by T. pallidum and P. gingivalis impacts osteoclastogenesis
and osteoclast activity. We specifically considered whether or not there is a synergistic effect of T.
pallidum and P. gingivalis on inflammatory responses that affect osteoclast differentiation and
activity. We believe that the inflammatory proteins released from the activated immune cells will
increase osteoclastogenesis and osteoclast activity in relation to increased alveolar bone resorption
and porosity.
Syphilis has generated considerable research and debate in bioarchaeology and long served
to promote methodological and theoretical advances within this field and other related fields
(Powell 2011). While this project helps set a precedent of connecting immunology and
bioarchaeology, this effect is increased by focusing on a disease of significant interest within
bioarchaeology. This project also represents an experimental complement in immunology to more
conventional analysis in bioarchaeology where immunological profiles for syphilis infection are
reconstructed through skeletal biomarkers of other conditions, particularly periodontal disease.
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The emerging question and first experimental step for this Senior Honors Thesis is to test if
immune cells activated by T. pallidum can influence osteoclastogenesis in vitro.

4. Objective
The specific objective of this thesis is to determine if in vitro exposure to stimulated
human immune cells pre-exposed to T. pallidum antigens or cells sequentially exposed to T.
pallidum antigens affects osteoclastogenesis and osteoclasts activity.
The long term objective of this project is to provide preliminary experimental evidence,
and to establish the potential immunological interplay between inflammatory responses against T.
pallidum and subsequently to other pathogens, such P. gingivalis, which is causal to PD, and how
this interplay may impact localized bone microenvironments (bone cells differentiation and
activity), enabling skeletal biomarkers, such as PD, to be used to reconstruct IP with empirical
certainty.
Our central hypothesis for the current experimental protocol is that the inflammatory
proteins expressed in hyper-activated immune cells by T. pallidum antigens increase in vitro
osteoclastogenesis and osteoclast activity accordingly with increased bone resorption.

5. Materials and Methods
In order to determine if exposing proliferating cells to supernatants collected from activated
immune cells will impact osteoclastogenesis and osteoclast activity multiple, distinct protocols
were used. Figure 2 shows the diagrammatic representation of the experimental protocols
described below.
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Figure 2: Diagrammatic representation of the experimental protocols: cells received from healthy donor, split between
immune activation protocol (top line) and osteoclastogenesis protocol (bottom line)

Monocytes +
Lymphocyte
s

Immune cells
extraction
(healthy donor)

Monocytes

First
stimulation
with T.

Second
stimulation
with P.
Collection of
supernatants with
expressed
inflammatory
proteins

Stimulation with osteoclastogenic/growing factors
(RANKL+MCS-F) =
Differentiation into osteoclasts

f. Immune cell culture
For the cells that will be exposed to infectious antigens and lysates, PBMCs were used
from healthy, voluntary donors that were collected at the University of Louisville Nephrology
Research Laboratory (IRB# 191.96 and 11.0334). PBMCs were isolated from the blood by using
dextran sedimentation and density centrifugation in a Percoll gradient at the Nephrology Research
Laboratory. In the primary laboratory (Dr. Crespo’s lab at the Department of Pathology and
Laboratory Medicine, School of Medicine)1, The PBMCs were then be washed with PBS, counted,
and resuspended in alpha Minimum Essential Medium (αMEM) completed with fetal bovine
serum and antibiotics. After the cells were resuspended, they were plated on 24-well plates with a
density of 4 x 106 cells per well. This aligned with protocols that have been used successfully by
the supervising faculty since 2012.
1: Medical Dental Research Building, room 236. The lab is directly supervised by Dr. R. Fernandez-Botran and Dr.
Vaclav Vetvicka.
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g. Osteoclast culture and generation
For the cells that were cultivated into osteoclasts, we used the PBMCs collected from
donors. We used unpurified PBMCs. The cells were cultured in αMEM completed. We used a 24well Corning Osteo Assay surface plate for monocyte differentiation and used RANKL ligand and
M-CSF to promote differentiation.

h. Cell culture reagents
PBMCs were stimulated with a variety of infectious agents. This includes
lipopolysaccharide (LPS from E. coli 0111:B4; general proxy for bacterial infection), antigens
from T. pallidum (Tp47 immunomodulatory antigen), and whole lysate from P. gingivalis (Pg).
The stock concentrations of the LPS, Tp47, and Pg was 1 mg/mL, 100 μg/μL, and 4x108/mL
respectively. Additionally, 10 μL, 2 μL, and 100 μL of LPS, Tp47, and Pg respectively were added
to the predetermined conditions for a final volume of 1 mL per well. Mature osteoclasts were
identified by TRAP, a marker specific to osteoclasts, through a staining kit (Takara Double
Staining Kit) and by the presence of three or more nuclei stained with Hematoxylin (Matsuzaki et
al. 1998).

i. Immune cell activation
Over the course of three days, PBMCs were exposed to bacterial antigens to understand the
reaction to single antigens and the effect of sequential exposure. The critical interaction explored
was T. pallidum followed by P. gingivalis (data not analyzed in this Thesis due to time
constraints). The PBMCs were exposed to Tp47 on Day 1 (24 hrs.). On Day 2, the supernatants
were collected. The cells were then washed, resuspended in fresh medium, and exposed to Pg for
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the following 24 hrs. The supernatants were again collected on Day 3 and then the cells were
discarded. The supernatants were used to analyze cytokine expression by measuring TNFα and
IFNg through enzyme-linked immunosorbent assay (ELISA). Similarly, we also used various
controls including conditions where cells were exposed to only one pathogen (untreated/Pg or
untreated/Tp47), conditions where cells were exposed to the same pathogen on both days (Pg/Pg or
Tp47/Tp47), conditions where the critical exposure sequence was reversed (Pg/Tp47), and
conditions where cells were not exposed to any pathogen (untreated).

j. Osteoclastogenesis and osteoclast activity
A general protocol was used to standardize conditions. The monocytes used in this protocol
were from the same donor as the cells used in the immune activation. This minimized the
confounding variables caused by assorted differences between donors. The differentiation protocol
typically lasted 12-14 days. We explored whether or not the shift in pro-inflammatory proteins
collected from activated immune cells affected osteoclastogenesis and/or osteoclast activity. We
included positive control and untreated conditions as well as conditions treated directly with
antigens or lysates (for P. gingivalis: 4x108/ml). For quantifying mature osteoclasts, we counted
positive TRAP cells with 3 or more nuclei using a TS100F Nikon inverted microscope. We
counted five subfields at 20X magnification for each condition analyzed in the osteoplate. The
final number was determined by averaging the number of osteoclasts counted in each of the five
subfields. For measuring osteoclast activity (data not shown in this Thesis due to time constraints),
we used a protocol that determines the optical density in the supernatants collected during the
osteoclastogenesis protocol after targeting TRAP expression was also used.
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6. Results
a. Cytokine expression by activated PBMCs
In the immune activation protocol, PBMCs were exposed to infectious antigens from T.
pallidum and E. coli (control) and lysate (P. gingivalis). This caused the cells to produce proinflammatory cytokines. The LPS generally stimulates Toll-like receptors (TLRs) and induces an
inflammatory response while the Tp47 antigens and Pg lysate will induce hyperinflammation. We
measured the expression of the cytokines TNFα and IFNg using ELISAs. We ran different
conditions (see Further Research section) for the immune activation protocols (first-24 hours and
second-48 hours exposure to different antigens). For this thesis, we prioritized the results, as
shown in Figures 3 and 4, for three conditions, untreated 24 hours (negative control), Tp47 24
hours, and LPS 24 hours (positive control), for TNFα and IFNg, respectively. The untreated 24
hours condition consisted of PBMCs not exposed to stimuli. The Tp47 24 hours condition
consisted of PBMCs treated with 2 μL of Tp47 (stock concentration: 100 μg/μL). The LPS 24
hours condition consisted of PBMCs treated with 10 μL of LPS (stock concentration: 1 mg/mL).
The results show that the PBMCs exposed to Tp47 produced relatively more TNFα (M =
648.54 pg/mL, SD = 4.72) and IFNg (M = 11.60 pg/mL, SD = 12.68) than the PBMCS in the
untreated condition which served as a baseline (TNFα: M = 1.10 pg/mL, SD = 0.85; IFNg: M =
1.31 pg/mL, SD = 1.87). The raw data of immune activation ELISAs for TNFα and IFNg are listed
in the appendix as 9a and 9b.
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Figure 3: Concentration of TNFα (pg/mL) in untreated, Tp47, and LPS conditions
Concentration of TNFα After Activation
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*The concentration of TNFα in the LPS condition was too high for the ELISA to read. Thus, the
concentration of TNFα in the LPS condition would be higher than the concentration of TNFα in the Tp47 condition.

Figure 4: Concentration of IFNg (pg/mL) in untreated, Tp47, and LPS conditions
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b. Activated immune cells and the effect on osteoclastogenesis
During the osteoclastogenesis protocol, differentiating monocytes were exposed to
supernatants from the immune activation protocol in order to determine if differential protein
expression by in vitro PBMCs (with differential expression of pro-inflammatory cytokines, such as
TNFα and IFNg) interfere with osteoclastogenesis. Figure 5 shows the number of mature, TRAP+
osteoclasts counted in each of the four main conditions: untreated (negative control), control
(positive control, exposed to RANK-L and M-CSF), control + untreated 24 hours supernatant
(CON+SP), and control + Tp47 24 hours supernatant (CON+SP47). The untreated condition
consisted of PBMCs without RANKL and M-CSF. The control condition consisted of PBMCs
with only RANKL and M-CSF. The control + untreated 24 hours supernatant condition consisted
of PBMCs with RANKL, M-CSF, and 100 μL of untreated 24 hours supernatant halfway through
the protocol. The control + Tp47 24 hours supernatant condition consisted of PBMCs with
RANKL, M-CSF, and 100 μL of Tp47 24 hours supernatant halfway through the protocol. Figure
6 shows the number of mature osteoclasts in the control + untreated 24 hours supernatant and
control + Tp47 24 hours supernatant conditions compared with the concentration of TNFα and
IFNg measured in each of the used supernatants.
The osteoclastogenesis results in Figure 5 show that, as expected, there were 0 mature,
TRAP+ osteoclasts in the untreated condition, 10.8 mature, TRAP+ osteoclasts on average per
field in the control condition, 8 mature, TRAP+ osteoclasts on average per field in the control +
untreated 24 hours supernatant condition, and 8.4 mature, TRAP+ osteoclasts on average per field
in the control + Tp47 24 hours supernatant condition. The results as displayed in Figure 6 indicate
that the higher concentrations of TNFα and IFNg (TNFα: 648.54 pg/mL; IFNg: 11.66 pg/mL) seen
in the Tp47 immune activation condition correspond to more mature, TRAP+ osteoclasts in the
21

control + Tp47 supernatant osteoclastogenesis condition (M = 8.4; SD = 4.72). In contrast, lower
concentrations of TNFα and IFNg (TNFα: 1.10 pg/mL; IFNg: 1.31 pg/mL) correspond with less
mature, TRAP+ osteoclasts in the control + untreated supernatant osteoclastogenesis condition (M
= 8; SD = 4.24). However, the statistical significance of this possible connection could not be
measured due to the sample size. Nevertheless, the morphologic phenotype of the osteoclasts in the
control + Tp47 24 hours supernatant condition was notably different than that of the osteoclasts in
the other conditions as can be seen in Figure 7. The raw data for the osteoclast counting is listed in
the appendix as 9c.

Figure 5: Osteoclast count for untreated, control, control + untreated supernatant, and control + Tp47
supernatant: osteoclast count based on average number of osteoclasts per field for each condition
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Figure 6: Osteoclast count for control + untreated supernatant and control + Tp47 supernatant combined with
concentration of TNFα and IFNg for the untreated and Tp47 conditions
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Figure 7: Osteoclastogenesis morphological results for untreated, control, control + untreated supernatant, and
control + Tp47 supernatant conditions: The marker identified was tartrate-resistant acid phosphatase (TRAP)
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7. Discussion
a. Immune activation results
In the immune activation protocols, the untreated condition served as a negative control
while the LPS condition served as a positive control. The untreated condition provided an overall
baseline of immune cell activity for the donor, and the LPS condition demonstrated that the cells
were alive and reactive to stimuli. LPS is a well-established stimulus of immune cells that causes
the cells to produce high levels of both pro-inflammatory cytokines, TNFα and IFNg. In this
regard, the LPS condition provided the opposite extreme to the untreated condition. With these two
points in mind, the Tp47 condition produced the amounts of TNFα and IFNg expected – more than
the untreated condition but less than the LPS condition. This indicates that the immune cells
reacted to the Tp47 by producing pro-inflammatory cytokines. This is essential to our objective
because it shows that the supernatants of the untreated and Tp47 conditions are relatively different
which could connect to differences in osteoclastogenesis and osteoclast activity.

b. Osteoclastogenesis results
The results of the osteoclastogenesis protocols indicate small differences between the
osteoclastogenesis condition and number of mature, TRAP+ osteoclasts. The measured number of
mature, TRAP+ osteoclasts for two protocols shows that the untreated condition (negative control)
has the least number of osteoclasts at zero, and the control condition (positive control) has the
highest number of osteoclasts at 10.8 on average per field. This is unsurprising as the monocytes in
the untreated condition were only given αMEM and nothing to promote differentiation. On the
other hand, the control osteoclasts were given ideal conditions of αMEM, RANKL, and M-CSF
which provided the opposite extreme compared to the untreated condition. With these conditions
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in mind, the control + untreated supernatant and the control + Tp47 supernatant conditions
produced a number of osteoclasts that fell between the two extremes, as expected. Within the two
conditions exposed to immune activation supernatants, the control + Tp47 supernatant condition
produced only slightly more osteoclasts than the control + untreated supernatant condition. This
does not seem to support our hypothesis that the inflammatory proteins expressed by activated
immune cells increase in vitro osteoclastogenesis.

c. Immune activation combined with osteoclastogenesis
When the results of the osteoclastogenesis and immune activation protocols are combined,
there seems to be no connection between the number of osteoclasts and the concentration of proinflammatory cytokines. The lower concentrations of TNFα and IFNg seen in the untreated
condition correspond to an only slightly smaller number of osteoclasts. The higher concentrations
of TNFα and IFNg seen in the Tp47 condition correspond to an only slightly higher number of
osteoclasts. These results indicate that there is not a connection between pro-inflammatory
cytokine concentration and osteoclastogenesis, but this could be due to high inter-sample
variability. While inter-sample variability will be controlled for in the statistical analysis, these
differences cannot be evaluated for statistical significance due to the sample size.

8. Conclusion
The results show four important outcomes. First, immune cells exposed to Tp47 produce
more TNFα and IFNg than the untreated condition (negative control) and less TNFα and IFNg than
the LPS condition (positive control). Second, the osteoclastogenesis conditions, control + untreated
supernatant and control + Tp47 supernatant, produce more osteoclasts than the untreated condition
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(negative control) and less osteoclasts than the control condition (positive control). Within the two
osteoclast conditions exposed to the immune activation supernatants, the control + Tp47
supernatant condition produced more osteoclasts than the control + untreated supernatant
condition. Last, the number of osteoclasts in the two osteoclastogenesis conditions exposed to the
immune activation supernatants do not seem to be connected to the concentration of TNFα and
IFNg measured in the supernatants.

9. Further Research
a. Strengths and limitations
This study had significant strengths and weaknesses that could inform future research. One
of the most notable strengths was using the same healthy human donor for the immune activation
and osteoclastogenesis protocols. This reduced the number of confounding variables connected to
donor differences that could explain the effect of adding supernatants to the osteoclastogenesis
conditions. It also simulated a more accurate interaction between the immune activation
supernatants and the osteoclastogenesis conditions by mimicking more closely interactions seen
within the body. Another strength of this research was changing the medium used in the immune
activation protocol to the same medium used in the osteoclastogenesis protocol. The original
protocol calls for complete medium RPMI 1640, but we switched to alpha Minimum Essential
Medium (αMEM). As with using the same donor for both protocols, this choice of using αMEM
instead of RPMI eliminated confounding interference due to the media used between the immune
activation supernatants and osteoclastogenesis conditions.
While using the same donor for both protocols was a noteworthy strength, this choice
presented its own set of challenges. Namely, there is a considerable inter-sample (each individual)
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variability due to the fact that each sample came from a different donor. While it can be assumed
that the underlying mechanisms work similarly in all humans, several factors can affect the results
such as immune system strength, medical history, lifestyle, and biological sex. Another significant
limitation was the sample size. As of now, we only have five immune activation samples and six
osteoclastogenesis samples (two osteoplates failed with successful osteoclastogenesis protocol).
While these can indicate trends and potential statistical differences, we cannot use statistical tests
to produce concrete results of significance.

b. Continuing research2
The sample size is a significant limitation to our conclusions. However, we are currently
completing more samples and plan to double our sample size in the coming weeks. With this
update, we plan to run statistical tests and provide more support for our conclusions. We will also
have completed the ELISA that measures TRAP expression to provide a critical piece of
information about osteoclast activity.
Outside of the data introduced in the results section, we also collected supernatants for the
second day (48 hours) of the immune activation protocol. While we are currently not using these
supernatants to interfere with the osteoclastogenesis protocols, we plan to slowly expand the
number of conditions tested and then utilize these supernatants. With this future expansion in
mind, we ran ELISAs measuring TNFα and IFNg for the 48 hours supernatants as well. Figure 8
and 9 show the concentrations of TNFα and IFNg, respectively, in all conditions after 48 hours.
The raw data for these charts is listed in the appendix as 9d and 9e.
The ELISA protocol also provides an area for future change. Several of the conditions had
concentrations of TNFα and IFNg that were either too low or too high for the machine to measure.
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To obtain quantities for these conditions, we relied on extrapolating through a simple proportional
equation. However, this equation assumed the cytokine concentration has a linear relationship with
the optical density. It could also only be used for conditions where an optical density reading was
available, so it could not be used on concentrations that were too high. In the future, we plan to
adjust the concentrations of the ELISA conditions before reading the plate. This will require
diluting samples that are too highly concentrated to obtain a reading. This only fixes the high
concentration problem, but it is an important step towards more accurate data.
Additionally, we plan to expand the number of cytokines we measure in the supernatants.
While TNFα and IFNg are frequently seen pro-inflammatory cytokines, there are other cytokines
that are seen in inflammatory processes such as IL-1 and IL-17. Currently, we are assuming that
TNFα or IFNg are responsible for any differences seen in the osteoclastogenesis conditions being
exposed to supernatants. This hypothesis can be investigated by using isolated TNFα and IFNg in
the conditions or by adding blocking antibodies to TNFα or IFNg. However, expanding the number
of cytokines measured is also important for determining the cause of any differences, especially if
the presence of TNFα or IFNg does not explain the results. Ultimately, measuring more proinflammatory cytokines will provide a more complete picture of the immune cell response.
2: Not all goals for Continuing Research will be accomplished or finished by the Thesis Defense, but we chose to
present them as part of the long-term objectives of the current project
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Figure 8: Concentration of TNFα in all 48 hours conditions
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* The concentrations of TNFα in the UNT/Pg and UNT/Tp47 conditions were too high for the ELISA to read
in all but one and two samples respectively. Thus, the listed number is not an accurate representation of the average
concentration for these conditions.

Figure 9: Concentration of IFNg in all 48 hours conditions
Concentration of IFNg After Activation (48 hours)
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the other conditions which indicates inconsistencies. That is why the results for this condition have been removed.
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11. Appendix
a. IAC 24 hours TNFα ELISA data

OIS-1
OIS-21
OIS-3
OIS-4
OIS-5

UNT
2.34
1.3
1.21
0.099
0.537

Tp47
645.207
651.876
+
+
+

Pg
+
558.576
+
+
+

LPS
+
+
+
+
+

Pg+Tp47
+

5

1

X
1.0972
648.5415
558.576
SD
0.85273542 4.71569512
N
5
5
5
1: RPMI was used as the media (MEM for the rest)
+: indicates concentration was too high for the ELISA to read
OIS-1: First sample of OsteoImmunology in Syphilis research
IAC: immune activation condition protocol

b. IAC 24 hours IFNg ELISA data

OIS-1
OIS-21
OIS-3
OIS-4
OIS-5

UNT
0
2
0.13
0.13
4.3

Tp47
8.7
33.34
0.13
6.694
9.12

Pg
26.964
22.431
3.3
3
4.3

LPS
211.229
91.131
18.925
13.188
85.235

X
1.312
11.5968
11.999
83.9416
SD
1.86528014 12.6769248 11.7122484 79.8258616
N
5
5
5
5
1: RPMI was used as the media (MEM for the rest)

Pg+Tp47
16.1

1
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c. Osteoclast counting for OCG 2, OCG 4, OCG 6, OCG 7, and OCG 8
OCG 2
OCG 4
OCG 6
OCG 7
OCG-8

UNT
0
0
0
0
0

AVG
SD

0
0

CON
17
12
11
7
7

CON+SP
10
13
4
5

10.8
8
4.1472883 4.2426407

CON+SP47
10
15
7
2
8
8.4
4.7222876

OCG: osteoclastogenesis protocol

d. IAC 48 hours TNFα ELISA data
UNT/UNT UNT/Pg UNT/Tp47
0
+
+
OIS-1
1.49
61.83
6.691
OIS-21
0.74
+
197.811
OIS-3
0.08
+
+
OIS-4
0.278
+
+
OIS-5
X
SD
N

OIS-1
OIS-21
OIS-3
OIS-4
OIS-5

0.5176
0.614784
5

61.83
5

102.251
135.142
5

Pg/UNT
3.38
9.055
16.042
869.19
590.385

Pg/Pg
34.564
1.16
248.16
339.356
114.391

297.61
406.675
5

147.526
143.359
5

Pg/Tp47 Tp47/UNT Tp47/Tp47 Tp47/Pg LPS/LPS
3.38
13.26
3.037
593.655
42.953
0.65
1.63
4
42.86
3.35
80.468
1.4
5.767
610.569
64.027
612.675
175.262
423.032
64.666
289.802
271.455
118.85
158.459
563.636 686.406

193.726
62.0804
118.859
X
258.794
80.2382
182.679
SD
5
5
5
N
1: Media: RPMI (MEM for the rest)

375.077
293.901
5

217.308
285.036
5

+: indicates concentration was too high for the ELISA to read
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e. IAC 48 hours IFNg ELISA data

OIS-1
OIS-21
OIS-3
OIS-4
OIS-5

UNT/UNT
7.4
3.8
0.13
0.5
0.3

UNT/Pg
373
11.3
43.2
0.7
51.3

X
SD
N

2.426
3.167393
5

96.8
155.745
5

OIS-1
OIS-21
OIS-3
OIS-4
OIS-5

UNT/Tp47 Pg/UNT
15.4
5.4
3
3
3.4
2.5
0.5
1
1.2
4.3
4.7
6.10246
5

3.24
1.68908
5

Pg/Pg
10.3
6.1
16.5
0.8
3.3
7.4
6.19032
5

Pg/Tp47 Tp47/UNT Tp47/Tp47 Tp47/Pg LPS/LPS
2
9.4
9
5.4
22
10.7
5
6.45
2
31.2
5
0.13
0.4
3
17.5
0.4
0.4
0.7
0.13
0.8
1.8
1
0.3
0.4
4.3

X
3.98
3.186
3.37
SD
4.11364
3.99324
4.07915
N
5
5
5
1: Media: RPMI (MEM for the rest)

2.186
2.14732
5

15.16
12.5866
5
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